Tenon Medical, Inc. (TNONW) stock
Close on Oct 30, 2026Market cap $1.37MP/E –Yield –
Tenon Medical, Inc. grew revenue 80.3% to $5.31M over the twelve months to Jun 30, 2026. Free cash flow was -$12.08M. At the latest close the market valued the company at $1.37M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.37M
- P/E ratio
- –
- Price to sales
- 0.26
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -883.03%
Fundamentals
- Revenue
- $5.31M
- Net income
- -$13.70M
- EPS, diluted
- -$59.50
- Free cash flow
- -$12.08M
- Book value per share
- -$5314.02
- Diluted shares
- 0M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 48,401
- Average volume (20 days)
- 98,166
- Beta (5 years)
- 1.00
- 52-week range
- $2.05 – $45.50
- RSI (14 days)
- 33.5
- Volatility (1 year)
- 219.7%
- Relative volume
- 0.04×
- WACC
- 10.0%
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | TNONW | S&P 500 | Difference | TNONW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -50.0% | -0.9% | −49.1 pts | ||
| 3 months | -63.0% | +2.1% | −65.1 pts | ||
| Year to date | -71.4% | +11.7% | −83.1 pts | ||
| 1 year | -81.9% | +12.4% | −94.3 pts | ||
| 3 years | -89.8% | +88.6% | −178.3 pts | -53.2% | +23.5% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Tenon Medical filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
About Tenon Medical
Surgical & Medical Instruments & Apparatus
Tenon Medical, Inc. is a medical device company that develops surgical solutions for sacro-pelvic disorders, particularly conditions affecting the sacroiliac joint that cause lower back pain. Its primary product offerings include The Catamaran SI Joint Fusion System, which utilizes a single titanium implant through a less invasive approach, and The SImmetry + SI Joint Fusion System, a minimally invasive lateral access system designed to achieve biological fusion across the joint. The company's solutions target clinical procedures including primary sacroiliac joint fusions, revisions of failed implants, and fusions performed adjacent to spine fusion constructs. The company serves healthcare providers, including surgeons, clinicians, and hospitals treating adult sacroiliac joint pathology.
Company profile, executives and historyTenon Medical stock: common questions
What is Tenon Medical's stock price?
TNONW closed at $0.00 on Oct 30, 2026, down 36.17% on the day. Over the past 52 weeks it traded between $2.05 and $45.50.
What is Tenon Medical's market cap?
Tenon Medical was worth $1.37M at the close on Oct 30, 2026: the share price times the diluted shares outstanding.
What is TNONW's P/E ratio?
Tenon Medical lost money over fiscal 2025 (diluted EPS -$59.50), so it has no meaningful P/E ratio.
How much revenue does Tenon Medical make?
Tenon Medical reported revenue of $5.31M for the twelve months to Jun 30, 2026, up 80.3% from a year earlier.
Does Tenon Medical pay a dividend?
No. Tenon Medical has not paid a cash dividend over the last twelve months.
How has TNONW stock performed over the past year?
Including dividends, TNONW returned -81.9% over the past year, against +12.4% for the S&P 500.
Who are Tenon Medical's competitors?
Companies most similar to Tenon Medical by business, industry and size include NONE., AURX, ECIA, NMTC, SINT.